# The COVID-19 Vaccination Rollout in Tanzania: The Role of Coordination in Its Success

**Authors:** Fredrick Rwegerera, Mwendwa Mwenesi, Belinda J. Njiro, Florian Tinuga, Pricilla Kinyunyi, Mary Rose Giattas, Alice Christensen, Ntuli Kapologwe, Adam Meshack, Joseline Ishengoma, Sophia A. Kagoye, Mwinyi I. Msellem, Mwanahamisi Hassan Magwangwala, Fatma Mohammed Kabole, Daniel Ali, Chizoba Wonodi

PMC · DOI: 10.3390/vaccines13050484 · Vaccines · 2025-04-30

## TL;DR

Tanzania's successful COVID-19 vaccination rollout was largely due to improved coordination among stakeholders, which helped increase vaccine coverage over time.

## Contribution

This study identifies how strengthening coordination mechanisms led to increased vaccination coverage in Tanzania during the pandemic.

## Key findings

- Initially weak coordination led to low vaccine coverage (3%) in the first period.
- Improved coordination and stakeholder engagement increased coverage from 4% to 25% in the second period.
- Strong coordination in the third period achieved 100% vaccination coverage of the target population.

## Abstract

Background: The national rollout of a vaccine is a complex and significant undertaking, made more challenging when the health system is experiencing shock, such as in a pandemic. Tanzania had relative success in its COVID-19 vaccination rollout compared to other African countries. Objectives: To better understand factors that contributed to this success, we examined the role of coordination (one of the six immunization system building blocks) on the outcomes of the national vaccine rollout. Methods: We obtained qualitative information from the published literature, COVID-19 vaccination program documents for Tanzania Mainland and Zanzibar, and reports from two documentation workshops with national, regional, and district stakeholders from the government, partners, academia, and civil society. Triangulating this information, we describe the COVID-19 vaccination coordination structure, the roles and responsibilities of its members, and the changes in their engagement and activities over the 18 months following the introduction of the COVID-19 vaccine. We also obtained quantitative data from the CHANJOCOVID system to analyze time trends in national COVID-19 vaccine coverage rates for the period August 2021 to December 2022. Results: We found that Tanzania had a multi-level, multi-partner integrated coordination mechanism that provided strategic direction, oversight, and guidance for the vaccination rollout. The coordination structure was initially weak but strengthened over time. Based on the level of coordination activities undertaken, we identified three periods marking different strengths of the coordination mechanisms, these corresponded with different trends in vaccination coverage in the mainland. In the first period (July–December 2021), the coordination mechanism was weak, and vaccine coverage was low, with only 3% of the target population vaccinated on the mainland. In the second period (January–May 2022), when stakeholder engagement was expanded and the coordination mechanism improved, there was a concurrent rise in vaccine coverage from 4% to 25%. In the third period (June–December 2022), coordination was further strengthened, and vaccination strategies were intensified; a corresponding increase in vaccine uptake was observed with coverage reaching 100% of the target population. Conclusions: Qualitative insights from the three time periods suggest a positive association between coordination strength and COVID-19 vaccine coverage. Coordination fostered collaboration, enhanced stakeholder engagement, and facilitated data-driven decision making. This enabled Tanzania to overcome complex challenges and achieve significant progress in vaccination coverage. Strong coordination and effective collaboration among stakeholders are essential mechanisms and processes to optimize vaccine delivery resources and ensure the equitable distribution and uptake of vaccines in Tanzania.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382), shock (MESH:D012769)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12116031/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12116031/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12116031/full.md

---
Source: https://tomesphere.com/paper/PMC12116031